Ancora Advisors’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-15,100
Closed -$127K 540
2015
Q4
$127K Buy
+15,100
New +$101K 0.02% 468

Ancora Advisors's OCAT Position: Q1 2016 in Review

Ancora Advisors sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 15,100 shares — an estimated $127K sold.

Ancora Advisors first reported a position in OCAT in Q4 2015 and held it in 1 quarter. The position peaked at $127K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Ancora Advisors reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Ancora Advisors sold 15,100 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $127K.
  • Ancora Advisors first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
  • Ancora Advisors's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $127K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Ancora Advisors's 13F filing for Q1 2016, filed 13 May 2016.